Response to: 'Tofacitinib for the treatment of polyarteritis nodosa: a literature review'. Correspondence on 'Tofacitinib for polyarteritis nodosa: a tailored therapy' by Rimar et al.
Ann Rheum Dis
; 81(10): e205, 2022 10.
Article
in En
| MEDLINE
| ID: mdl-32907803
Full text:
1
Database:
MEDLINE
Main subject:
Polyarteritis Nodosa
Limits:
Humans
Language:
En
Journal:
Ann Rheum Dis
Year:
2022
Type:
Article
Affiliation country:
Israel